Theodoros Kyriakides, Senior Neurologist at the Cyprus Institute of Neurology & Genetics, Prof of Neurology/Life Control Module Convenor/Lead for NeuroPlus  at the medical School presented the results of his latest study titled ‘TTRMet30 Amyloid Neuropathy in Cyprus, the Curse of the Crusaders.’

TTRMet30 amyloidotic neuropathy is an autosomal dominant sensorimotor neuropathy due to amyloid deposition. Cyprus is an endemic focus of the disease in Europe, although to a lesser degree thanPortugal and Sweden which are the other two loci.  It is speculated that this disease was introduced in Cyprus perhaps by the Crusaders in the 13th century and affects only the Greek speaking Christian community. Although liver transplantation is currently the only lifesaving therapy available,  there is a lot research being carried out that is already beginning to provide other therapeutic opportunities.